Full Text View
Tabular View
No Study Results Posted
Related Studies
Immunotherapy Using Lenalidomide + Bystander Vaccine in High Risk Myelodysplastic Syndrome (MDS)
This study is ongoing, but not recruiting participants.
Study NCT00840931   Information provided by H. Lee Moffitt Cancer Center and Research Institute

First Received on February 4, 2009.   Last Updated on July 10, 2014   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Sponsors listed in this trial